Moolec Science SA Ordinary Shares and ProKidney Corp. Class A Ordinary Shares
Moolec Science SA, a science-based ingredient company, engages in developing ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology in Cayman Islands and internationally. It produces animal proteins in plants to heal the meat production system. The company is based in Grand Cayman, Cayman Islands.
Open MLEC dashboard ↗ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Open PROK dashboard ↗You've viewed 3 distinct stock or comparison pages today. Sign in for 10 views per day.
Sign in →